Eli Lilly's experimental cancer drug cuts recurrence risk in early-stage lung cancer patients

Eli Lilly and Co. LLY on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo ...
Fierce Pharma

Lilly's rare cancer drug Retevmo looks to broaden reach with adjuvant trial win

Some six years after the FDA approved Eli Lilly’s Retevmo to treat lung a | Six years after the FDA approved Eli Lilly’s ...
CURE

ASCO Updates First-Line Treatment for Stage 4 EGFR Lung Cancer

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

Lilly’s Retevmo boosts event-free survival in early-stage NSCLC

Eli Lilly’s oral targeted cancer therapy, Retevmo, has shown benefit as an adjunctive therapy in a Phase III trial in ...
Medscape

SABR Ties SOC Surgery in Non-Small Cell Lung Cancer Survival

Stereotactic ablative radiotherapy (SABR) offers patients with early-stage non-small cell lung cancer (NSCLC) an effective alternative to the standard of care surgery — with significantly fewer severe ...
Cure Today

Advancements Reshape Treatment for Non-Small Cell Lung Cancer

Zipalertinib showed a 35% overall response rate in EGFR exon 20 mutated NSCLC, with notable CNS activity and a favorable safety profile. NeoADAURA trial highlighted the feasibility of neoadjuvant EGFR ...

Eli Lilly Advances Gene Editing And Lung Cancer Programs With Valuation Upside

Eli Lilly (NYSE:LLY) reached a second milestone in its CRISPR gene editing collaboration with Scribe Therapeutics, advancing programs in neurological and neuromuscular diseases. The company reported ...
SurvivorNet on MSN

Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Fred Hutch

Stages of Lung Cancer

You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...
ascopubs.org

Effects of the COVID-19 pandemic on staging and treatment patterns in non-small cell lung cancer: A large national study.

Patterns of confirmatory germline testing in patients with somatic BRCA1/2 pathogenic variants across solid tumor types in a community oncology setting. Risk of hypertension in patients newly ...

Lung Cancer Rising Among Never-Smokers. Screening For This Group Lags

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.
WebMD

What Is HER2-Mutated Non-Small-Cell Lung Cancer?

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...